3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
5
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Vomiting
8
Nausea
5
Neoplasms
2
Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Postoperative Nausea and Vomiting
1
Post-Dural Puncture Headache
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hematologic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Dexamethasone
64
Cyclophosphamide
40
Bortezomib
37
Melphalan
24
Lenalidomide
23
Thalidomide
17
pomalidomide
16
fludarabine
12
daratumumab
11
carfilzomib
10
Filgrastim
8
Doxorubicin
8
Busulfan
6
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
isatuximab
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
Calcium Dobesilate
4
liposomal doxorubicin
3
ixazomib
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Multiple Myeloma
×
Aprepitant
×
Clear all
NCT00571168
2010-01-12
EmNa
Heidelberg University
Phase 3
Unknown
362 enrolled